Related Experiment Video
Updated: Aug 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and
Deepti S Wilkinson1, Stacey K Ogden, Sabrina A Stratton
1Department of Biochemistry and Molecular Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
We purified the oncoprotein SnoN and found that it functions as a corepressor of the tumor suppressor p53 in the regulation of the hepatic alpha-fetoprotein (AFP) tumor marker gene. p53 promotes SnoN and histone deacetylase interaction at an overlapping Smad binding, p53 regulatory element (SBE/p53RE) in AFP. Comparison of wild-type and p53-null mouse liver tissue by using chromatin immunoprecipitation (ChIP) reveals that the absence of p53 protein correlates with the disappearance of SnoN at the SBE/p53RE and loss of AFP developmental repression. Treatment of AFP-expressing hepatoma cells with transforming growth factor-beta1 (TGF-beta1) induced SnoN transcription and Smad2 activation, concomitant with AFP repression. ChIP assays show that TGF-beta1 stimulates p53, Smad4, P-Smad2 binding, and histone H3K9 deacetylation and methylation, at the SBE/p53RE. Depletion, by small interfering RNA, of SnoN and/or p53 in hepatoma cells disrupted repression of AFP transcription. These findings support a model of cooperativity between p53 and TGF-beta effectors in chromatin modification and transcription repression of an oncodevelopmental tumor marker gene.
Insights
The oncoprotein SnoN acts as a tumor suppressor by repressing alpha-fetoprotein (AFP) gene transcription. This function is dependent on its interaction with p53, a key tumor suppressor protein.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- The oncoprotein SnoN's role in tumor suppression is not fully understood.
- Alpha-fetoprotein (AFP) is a key tumor marker gene in liver cancer.
- The tumor suppressor p53 is a critical regulator of cell growth and tumor suppression.
Purpose of the Study:
- To investigate the function of SnoN in regulating the hepatic alpha-fetoprotein (AFP) tumor marker gene.
- To elucidate the interaction between SnoN and the tumor suppressor p53 in AFP gene regulation.
- To understand the role of transforming growth factor-beta1 (TGF-beta1) signaling in AFP repression.
Main Methods:
- Purification of the oncoprotein SnoN.
- Chromatin immunoprecipitation (ChIP) assays in wild-type and p53-null mouse liver tissue.
- Small interfering RNA (siRNA) mediated depletion of SnoN and p53 in hepatoma cells.
- Analysis of histone modifications and protein binding at the AFP gene locus.
Main Results:
- SnoN functions as a corepressor of the tumor suppressor p53 in regulating AFP gene transcription.
- p53 facilitates the interaction of SnoN with histone deacetylases at the AFP gene.
- Absence of p53 leads to loss of SnoN binding and AFP gene repression.
- TGF-beta1 treatment induces SnoN, activates Smad2, and represses AFP transcription.
- TGF-beta1 signaling promotes p53, Smad4, and P-Smad2 binding, and histone deacetylation at the AFP locus.
- Depletion of SnoN or p53 disrupts AFP gene repression.
Conclusions:
- SnoN and p53 cooperate to repress AFP transcription through chromatin modification.
- The p53-SnoN complex plays a critical role in the developmental repression of the AFP tumor marker gene.
- These findings reveal a novel mechanism of tumor suppression involving p53 and TGF-beta signaling in regulating oncodevelopmental genes.
Related Concept Videos
Abnormal Proliferation
TGF - β Signaling Pathway
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle

